The DOI matches its Crossref record; 352 of the 356 references it cites were found in a registry or an index; none of the 390 sources its claims cite is checked for support yet.
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: The aim was to formulate practice guidelines for the diagnosis and treatment of polycystic ovary syndrome (PCOS). PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize supporting evidence. CONCLUSIONS: We suggest using the Rotterdam criteria for diagnosing PCOS (presence of two of the following criteria: androgen excess, ovulatory dysfunction, or polycystic ovaries). Establishing a diagnosis of PCOS is problematic in adolescents and menopausal women. Hyperandrogenism is central to the presentation in adolescents, whereas there is no consistent phenotype in postmenopausal women. Evaluation of women with PCOS should exclude alternate androgen-excess disorders and risk factors for endometrial cancer, mood disorders, obstructive sleep apnea, diabetes, and cardiovascular disease. Hormonal contraceptives are the first-line management for menstrual abnormalities and hirsutism/acne in PCOS. Clomiphene is currently the first-line therapy for infertility; metformin is beneficial for metabolic/glycemic abnormalities and for improving menstrual irregularities, but it has limited or no benefit in treating hirsutism, acne, or infertility. Hormonal contraceptives and metformin are the treatment options in adolescents with PCOS. The role of weight loss in improving PCOS status per se is uncertain, but lifestyle intervention is beneficial in overweight/obese patients for other health benefits. Thiazolidinediones have an unfavorable risk-benefit ratio overall, and statins require further study.
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline recommends using the Rotterdam criteria to diagnose PCOS in adults and emphasizes excluding mimics and assessing associated metabolic, cardiovascular, endometrial, mood, and sleep morbidity. It recommends hormonal contraceptives as first-line management for menstrual abnormalities and hirsutism/acne, clomiphene (or comparable estrogen modulators) as first-line therapy for anovulatory infertility, and metformin for T2DM/IGT or as second-line therapy for menstrual irregularity when hormonal contraceptives cannot be used.
Key findings
- PCOS diagnosis in adults should be made if two of three Rotterdam criteria are met—androgen excess, ovulatory dysfunction, or polycystic ovaries—after excluding thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia; in adolescents, diagnosis should require clinical and/or biochemical hyperandrogenism plus persistent oligomenorrhea, because anovulatory symptoms and PCO morphology are not sufficient.
- Women with PCOS are at increased risk for impaired glucose tolerance and type 2 diabetes: the guideline states a 5- to 10-fold increased risk of developing T2DM, with overall glucose intolerance prevalence of 30–35% and T2DM in 3–10%; nonobese women with PCOS had 10–15% IGT and 1–2% T2DM.
- Hirsutism is present in approximately 65–75% of patients with PCOS, and PCOS represents the major cause of hirsutism; in a large study of patients with clinical hyperandrogenism, 72.1% of 950 patients were diagnosed with PCOS.
- Endometrial cancer risk is increased: a 31-year UK follow-up showed a 3.5 increased relative risk, and a meta-analysis reported RR = 2.7 (95% CI, 1.0–7.29), confirmed by a subsequent systematic review with a 3-fold increased risk.
- Depression and sleep-disordered breathing are also increased: one study reported major depression episode/recurrent depression OR 3.8 (95% CI, 1.5–8.7; P = .001) and suicide attempts seven times higher in PCOS cases vs controls; women with PCOS were 30 times more likely to have sleep-disordered breathing and nine times more likely to have daytime sleepiness after controlling for BMI.
Methods
- An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline using the GRADE system to describe recommendation strength and evidence quality.
- Consensus was reached through one group meeting, several conference calls, and e-mail communications; committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts.
- Two systematic reviews were conducted to summarize supporting evidence; recommendations use “we recommend” with number 1 for strong recommendations and “we suggest” with number 2 for weak recommendations, with cross-filled circles indicating evidence quality.
Limitations
- The guideline states that there are no adequately powered, randomized, double-blind, placebo-controlled trials in adolescents with PCOS; no large randomized trials of exercise in PCOS; and no long-term data assessing the effect of hormonal contraceptives on glucose tolerance in nondiabetic and diabetic women with PCOS.
- It states that there are currently no diagnostic criteria for PCOS in perimenopausal and menopausal women, no age-related testosterone cutoffs, and that testosterone assays used to diagnose hyperandrogenemia in women are imprecise.
- It notes that the Rotterdam ultrasound PCO criteria were not validated for adolescents, that there is a lack of well-defined cutoff points for androgen levels during normal pubertal maturation, and that many recommendations are weak because evidence is limited or inconclusive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 201 Not checked · 50 Own results and interpretations
In the paper
“However, hirsutism was a major symptom in about 60% of adolescents in one study (27) and may be suggestive of PCOS in adolescents (28).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 1.0 Diagnosis of PCOS
What the sources say
- Not checked yetcites [27] Pfeifer SM, Kives S Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin North Am. 2009; 36: 129– 152. 19344852
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“but our systematic review did not confirm this (211).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [211] Domecq JP, Prutsky G, Mullan R, et al Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013–2385. 24092832
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“although there were significant improvements in some metabolic parameters (mainly glycemic effects related to improvements in fasting blood glucose and insulin levels) (249, 250).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [249] Tang T, Glanville J, Orsi N, Barth JH, Balen AH The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21: 1416– 1425. 16501038
- Not checked yetcites [250] Domecq JP, Prutsky G, Mullan R, et al Adverse effects of common treatments for polycystic ovary syndrome: a systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013-2374. PMC5399491 24092830
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found little evidence to support lifestyle change as an infertility treatment”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Our own meta-analysis showed that weight loss had minimal effects on hirsutism and fertility”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [249] Tang T, Glanville J, Orsi N, Barth JH, Balen AH The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21: 1416– 1425. 16501038
- Not checked yetcites [250] Domecq JP, Prutsky G, Mullan R, et al Adverse effects of common treatments for polycystic ovary syndrome: a systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013-2374. PMC5399491 24092830
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
146 more claims
Create a free account to see all 252 claims and to verify the 390 references still open.
- It may state two separate claims as one. 78
- Probably not a substantial claim. 34
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on current guidelines, metformin is indicated in PCOS in some scenarios to improve fertility (Teede et al. , 2011; Legro et al. , 2013), for management of menstrual irregularity if women are unable to take OCPs, and in co-existent prediabetes or DM2, where lifestyle modification fails (Legro et al. , 2013).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Legro et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the interim there is inadequate evidence on the impact of metformin on glucose tolerance in prediabetes and DM2 specifically in PCOS, but based on data in general populations, current guidelines recommend using metformin in obese women with PCOS who have prediabetes or DM2 (Legro et al. , 2013).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Legro et al. , 2013
Experimental — accuracy not yet measuredIn the citing paper
“It is indicated in combination with COCs, especially for overweight or obese patients, or when COCs are contraindicated [46].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [46]
Citations
Cites
1 retracted
Items 201–352 of 352
Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance
Zimmermann, S., Phillips, R. A., Dunaif, A. E., Finegood, D. T., Wilkenfeld, C., Ardeljan, M., Gorlin, R., & Krakoff, L. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639952 · Cited by 144
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
Recabarren, S. E., Smith, R., Ríos, R., Maliqueo, M. A., Echiburú, B., Ethel Codner, D., CASSORLA, F. G., Rojas, P., & Sir‐Petermann, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2256 · Cited by 143
Standards for ovarian volume in childhood and puberty
Bridges, N., Cooke, A., Healy, M. J. R., Hindmarsh, P. C., & Brook, C. G. D. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56160-3 · Cited by 143
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Alsamarai, S., Adams, J. M., Murphy, M. K., Post, M. D., Hayden, D. L., Hall, J. E., & Welt, C. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0839 · Cited by 143
Self-citationPreconception Care of Women With Diabetes
Kendrick, J. M. (2004) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/00005237-200401000-00003 · Cited by 143
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.002 · Cited by 138 · cited 1×
“However, metformin did not increase weight loss in patients using diet and exercise programs (255, 257).”
BackgroundSelf-citationMastorakos, G., Koliopoulos, C., & Creatsas, G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02993-x · Cited by 137
Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?
Stener‐Victorin, E., Holm, G., Labrie, F., Nilsson, L., Janson, P. O., & Ohlsson, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1908 · Cited by 135
Tasali, E., Chapotot, F., Leproult, R., Whitmore, H. R., & Ehrmann, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1187 · Cited by 135
Self-citationHomburg, R., Berkovitz, D., Levy, T., Feldberg, D., Ashkenazi, J., & Ben‐Rafael, Z. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56287-6 · Cited by 134
Norman, R. J., Wu, R., & Stankiewicz, M. T. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05838.x · Cited by 131
Hudecova, M., Holte, J., Olovsson, M., & Sundstrom Poromaa, I. (2009) · Human Reproduction · doi:10.1093/humrep/den482 · Cited by 127
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
Lowenstein, E. J. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2006.00077.x · Cited by 127
Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth
Harwood, K., Vuguin, P. M., & DiMartino-Nardi, J. (2007) · Hormone Research in Paediatrics · doi:10.1159/000101538 · Cited by 125
Coney, P., Washenik, K., Langley, R. G. B., DiGiovanna, J. J., & Harrison, D. D. (2001) · Contraception · doi:10.1016/s0010-7824(01)00208-6 · Cited by 123
Glasow, A., Breidert, M., Haidan, A., Anderegg, U., Kelly, P. A., & Bornstein, S. R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768882 · Cited by 123
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Bickerton, A. S. T., Clark, N. M., Meeking, D. R., Shaw, K. M., Crook, M. A., Lumb, P. J., Turner, C., & Cummings, M. H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015271 · Cited by 119
Cobin, R. H., Futterweit, W., Nestler, J. E., Reaven, G. M., Jellinger, P. S., Handelsman, Y., Redmond, G. P., & Thatcher, S. S. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.125 · Cited by 117
Zain, M. M., Jamaluddin, R., Ibrahim, A., & Norman, R. J. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.002 · Cited by 115
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115
Self-citationAbnormal aminotransferase activity in women with polycystic ovary syndrome
Schwimmer, J. B., Khorram, O., Chiu, V. Y., & Schwimmer, W. B. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.08.020 · Cited by 113
Endometrial carcinoma; ovarian dysfunction — a risk factor in young women
Dahlgren, E., Friberg, L.-G., Johansson, S., Lindström, B., Odén, A., Samsioe, G., & Janson, P. O. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90092-y · Cited by 112
Sam, S., Legro, R. S., Essah, P. A., Apridonidze, T., & Dunaif, A. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602025103 · Cited by 111
Self-citationDiamanti‐Kandarakis, E. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2009.09.005 · Cited by 111
Nieuwenhuis-Ruifrok, A. E., Kuchenbecker, W. K. H., Hoek, A., Middleton, P., & Norman, R. J. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn043 · Cited by 110 · cited 2×
“A systematic review and meta-analysis demonstrated that there was significant weight loss in trials using metformin compared with placebo in women with PCOS (255).”
BackgroundÖzdemir, S., Özdemir, M., Görkemli, H., Kıyıcı, A., & Bodur, S. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903353284 · Cited by 110
Metformin treatment is effective in obese teenage girls with PCOS
Leo, V. D., Musacchio, M. C., Morgante, G., Piomboni, P., & Petraglia, F. (2006) · Human Reproduction · doi:10.1093/humrep/del185 · Cited by 109
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 108
Aromatase inhibitors for PCOS: a systematic review and meta-analysis
Misso, M. L., Wong, J. L. A., Teede, H. J., Hart, R. J., Rombauts, L. J. F., Melder, A., Norman, R. J., & Costello, M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms003 · Cited by 107
Anovulation after Precocious Pubarche: Early Markers and Time Course in Adolescence
Ibáñez, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2691 · Cited by 107
Ferriman Gallwey Self-Scoring I: Performance Assessment in Women with Polycystic Ovary Syndrome
Wild, R. A., Vesely, S. K., Beebe, L. A., Whitsett, T. L., & Owen, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2243 · Cited by 106
Pasquali, R., Gambineri, A., Cavazza, C., Gasparini, D. I., Ciampaglia, W., Cognigni, G. E., & Pagotto, U. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0692 · Cited by 104
Self-citationHomburg, R., Hendriks, M. L., König, T. E., Anderson, R. A., Balen, A. H., Brincat, M., Child, T. J., Davies, M. C., D’Hooghe, T. M., Martinez, A., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der401 · Cited by 102
Rimm, E. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., ROSNER, B. A., Hennekens, C. H., & Speizer, F. E. (1992) · Diabetologia · doi:10.1007/bf00401427 · Cited by 101
Metformin Versus Insulin for the Treatment of Gestational Diabetes
Rowan, J., Hague, W. M., Gao, W., BATTIN, M. R., & Moore, M. P. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000327772.43649.2a · Cited by 99
Carcinoma of the endometrium in young women.
Speert, H. (1949) · PubMed · Cited by 98
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Tso, L. O., Costello, M., Andriolo, R. B., & de Freitas, V. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006105.pub2 · Cited by 97
Banaszewska, B., Pawelczyk, L. A., Spaczyński, R., & Dulęba, A. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1674 · Cited by 96
Tarkun, İ., Çetinarslan, B., Türemen, E., Şahin, T., Cantürk, Z., & Komşuoğlu, B. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01948 · Cited by 96
The metabolic profile in patients with skin tags
Sarı, R., Akman, A., Alpsoy, E., & Balcı, M. K. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0086-5 · Cited by 94
Rosenfield, R. L., Ghai, K., Ehrmann, D. A., & Barnes, R. B. (2000) · PubMed · Cited by 93
Self-citationProlactin and adrenal androgen secretion
VERMEULEN, A., & ANDO, S. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb02772.x · Cited by 93
Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial
Legro, R. S., Pauli, J. G., Kunselman, A. R., Meadows, J. W., Kesner, J. S., Zaino, R. J., Demers, L. M., Gnatuk, C. L., & Dodson, W. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2287 · Cited by 93
Self-citationPredictors of Pregnancy in Women with Polycystic Ovary Syndrome
Rausch, M., Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., McGovern, P. G., Cataldo, N. A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0545 · Cited by 93
Self-citationMorse, C. B., Sammel, M. D., Shaunik, A., Allen‐Taylor, L., Oberfoell, N. L., Takács, P., Chung, K., & Barnhart, K. T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.037 · Cited by 92
Ibáñez, L., Potau, N., Ferrer, A., Rodríguez‐Hierro, F., Marcos, M. V., & de Zegher, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020926 · Cited by 91
Adolescent Female Acne: Etiology and Management
Olutunmbi, Y., Paley, K., & English, J. C. (2008) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2007.07.004 · Cited by 90
Mevastatin inhibits ovarian theca–interstitial cell proliferation and steroidogenesis
Izquierdo, D. M., Foyouzi, N., Kwintkiewicz, J., & Dulęba, A. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.037 · Cited by 90
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Bhattacharya, S. M., & Jha, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.025 · Cited by 88
de Lédinghen, V., Ratziu, V., Causse, X., Bail, B. L., Capron, D., Renou, C., Pilette, C., Oulès, V., Gelsi, È., Oberti, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.008 · Cited by 88
Metformin Versus Insulin for the Treatment of Gestational Diabetes
Rowan, J., Hague, W. M., Gao, W., BATTIN, M. R., & Moore, M. P. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344705.95925.07 · Cited by 86
Epidemiological studies of exercise in diabetes prevention
Hu, G., Lakka, T. A., Kilpeläinen, T. O., & Tuomilehto, J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-030 · Cited by 85
Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
Matilainen, V., Laakso, M., Hirsso, P., Koskela, P. U., Rajala, U., & Keinanen-Kiukaanniemi, S. M. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000070200.72977.c6 · Cited by 85
Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome
Orio, F., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Vuolo, L., Russo, T., Tolino, A., Lombardi, G., Colao, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0216 · Cited by 84
Abbott, D. H., Zhou, R., Bird, I. M., Dumesic, D. A., & Conley, A. J. (2008) · KARGER eBooks · doi:10.1159/000134831 · Cited by 84
Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
Sam, S., Coviello, A. D., Sung, Y., Legro, R. S., & Dunaif, A. E. (2008) · Diabetes Care · doi:10.2337/dc07-2190 · Cited by 84
Self-citation(1994) · PubMed · Cited by 83
Moran, L., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq051 · Cited by 83
Elting, M. W., Kwee, J., Korsen, T. J. M., Rekers-Mombarg, L. T. M., & Schoemaker, J. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00152-3 · Cited by 81
Arslanian, S. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.66 · Cited by 81
Self-citationRosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Self-citationVgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A. M., Kales, A., & Chrousos, G. P. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200107000-00017 · Cited by 80
Self-citationMoro, C., Pasarica, M., Elkind-Hirsch, K. E., & Redman, L. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0051 · Cited by 79
JOHNSON, N. P., Stewart, A., Falkiner, J., Farquhar, C. M., Milsom, S. R., Singh, V. P., Okonkwo, Q. L., & Buckingham, K. (2010) · Human Reproduction · doi:10.1093/humrep/deq100 · Cited by 78
Rautio, K., Tapanainen, J. S., Ruokonen, A., & Morin-Papunen, L. C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01840 · Cited by 78
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565.pub2 · Cited by 77
Ortega, H. H., Rey, F., Velázquez, M. M. L., & Padmanabhan, V. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.082719 · Cited by 77
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Ludlam, W. H. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00353-1 · Cited by 77
Polycystic ovary syndrome in adolescence--a therapeutic conundrum
Homburg, R., & Lambalk, C. B. (2004) · Human Reproduction · doi:10.1093/humrep/deh207 · Cited by 76
Effect of seven low-dose combined oral contraceptive preparations on carbohyrate metabolism
van der Vange, N., Kloosterboer, H. J., & Haspels, A. A. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90355-3 · Cited by 76
Dreisler, E., Sørensen, S. S., Ibsen, P. H., & Lose, G. (2009) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.6256 · Cited by 75
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome
Tıraş, M. B., Yalcin, R., Noyan, V., Maral, İ., Yıldırım, M., Dörtlemez, Ö., & Daya, S. K. (1999) · Human Reproduction · doi:10.1093/humrep/14.8.1949 · Cited by 74
Thomson, R. L., Buckley, J. D., Moran, L., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02177.x · Cited by 70
Gaspard, U., Endrikat, J., Desager, J. P., Buicu, C., Gerlinger, C., & Heithecker, R. (2004) · Contraception · doi:10.1016/j.contraception.2003.11.003 · Cited by 70
Catch‐up growth in childhood and death from coronary heart disease: longitudinal study
(2000) · Ambulatory Child Health · doi:10.1046/j.1467-0658.2000.62(10).x · Cited by 70
Arnaldo Porcile, J., & Gallardo, E. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54291-5 · Cited by 69
Cagnacci, A., Paoletti, A. M., Renzi, A., Orrù, M., Pilloni, M., Melis, G. B., & Volpe, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030328 · Cited by 69
Reproductive endocrinology of adolescent polycystic ovary syndrome
Shayya, R. F., & Chang, R. J. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02421.x · Cited by 68
Treatment of PCOS in adolescence
Warren-Ulanch, J., & Arslanian, S. A. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.002 · Cited by 68
Self-citationKiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199209000-00020 · Cited by 68
Polycystic Ovary Syndrome in the Adolescent
Pfeifer, S. M., & Kives, S. L. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.12.004 · Cited by 67
Tang, T. H., Glanville, J., Hayden, C. J., White, D. M., Barth, J. H., & Balen, A. H. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197800.07214.dc · Cited by 66
Cagnacci, A., Ferrari, S., Tirelli, A., Zanin, R., & Volpe, A. (2008) · Contraception · doi:10.1016/j.contraception.2008.09.002 · Cited by 64
Raja-Khan, N. T., Kunselman, A. R., Hogeman, C. S., Stetter, C., Demers, L. M., & Legro, R. S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.040 · Cited by 63
Self-citationGarg, S. K. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510380055037 · Cited by 63
Bekx, M. T., Connor, E. L., & Allen, D. B. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2009.04.004 · Cited by 59
Ketel, I. J. G., Stehouwer, C. D. A., Henry, R. M. A., Serné, E. H., Hompes, P. G. A., Homburg, R., Smulders, Y. M., & Lambalk, C. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0868 · Cited by 59
Florakis, D., Diamanti‐Kandarakis, E., Katsikis, I., Nassis, G. P., Karkanaki, A., Georgopoulos, N. A., & Panidis, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803777 · Cited by 58
Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells
Song, S.-Y., Nomizu, M., Yamada, Y., & Kleinman, H. K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g · Cited by 57
Magnussen, L. V., Mumm, H., Andersen, M., & Glintborg, D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.035 · Cited by 57
Skouby, S. O., Endrikat, J., Düsterberg, B., Schmidt, W., Gerlinger, C., Wessel, J., Goldstein, H., & Jespersen, J. (2005) · Contraception · doi:10.1016/j.contraception.2004.08.017 · Cited by 57
Apter, D. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00020-4 · Cited by 56
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Lee, P. A., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.048 · Cited by 56
Self-citationThe Complex Relationship between Hypothalamic Amenorrhea and Polycystic Ovary Syndrome
Wang, J. G., & Løbo, R. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1716 · Cited by 55
Watanabe, R. M., Azen, C., Roy, S., Perlman, J. A., & Bergman, R. N. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962320 · Cited by 55
Winkler, U. H., & Sudik, R. (2008) · Contraception · doi:10.1016/j.contraception.2008.08.011 · Cited by 51
Sokalska, A., Piotrowski, P. C., Rzepczynska, I. J., Cress, A. B., & Dulęba, A. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0770 · Cited by 50
d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review
Galazis, N., Galazi, M., & Atiomo, W. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.538099 · Cited by 46 · cited 1×
“Although there are no known serious adverse events related to Dchiro-inositol therapy, there are concerns about the formulation of the drug and limited evidence of its efficacy (275).”
BackgroundCrook, D., Godsland, I. F., Worthington, M., Felton, C. V., Proudler, A. J., & Stevenson, J. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90279-r · Cited by 46
Glasow, A. B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.3103 · Cited by 45
Timmermans, A., Opmeer, B. C., Khan, K. S., Bachmann, L. M., Epstein, E., Clark, T. J., Gupta, J., Bakour, S. H., T, V. D. B., van Doorn, H. C., et al. (2010) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-47277 · Cited by 44
Pawelczak, M., Kenigsberg, L., Milla, S. S., Liu, Y., & Shah, B. C. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0013 · Cited by 43
Dokras, A., Clifton, S. C., Futterweit, W., & Wild, R. D. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318227fc6a · Cited by 43
Kauffman, R. P., Baker, T. E., Baker, V. M., Kauffman, M. M., & Castracane, V. D. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903184084 · Cited by 42
Endothelial Function Varies According to Insulin Resistance Disease Type
Beckman, J. A., Goldfine, A. B., Dunaif, A. E., Gerhard‐Herman, M. D., & Creager, M. A. (2007) · Diabetes Care · doi:10.2337/dc06-2142 · Cited by 42
Ghizzoni, L., Virdis, R., Vottero, A., Cappa, M., Street, M. E., Zampolli, M., Ibáñez, L., & Bernasconi, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636275 · Cited by 41
Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
Frempong, B. A., Ricks, M., Sen, S., & Sumner, A. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2599 · Cited by 40
Guttmann‐Bauman, I. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.5.499 · Cited by 40
SHULMAN, L. P. (2010) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(10)79202-x · Cited by 40
Preconception Care of Women With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s91 · Cited by 38
Combination contraceptives: effects on weight
Gallo, M. F., Grimes, D. A., Schulz, K. F., & Helmerhorst, F. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003987 · Cited by 37
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
Lopez, L. M., Grimes, D. A., & Schulz, K. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006133.pub3 · Cited by 36
Oral Contraceptives and the Management of Hyperandrogenism–Polycystic Ovary Syndrome in Adolescents
Hillard, P. J. A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.04.012 · Cited by 35
Ekmekçi, T. R., Uçak, S., Basat, O., Köşlü, A., & Altuntaş, Y. (2007) · PubMed · doi:10.1684/ejd.2007.0095 · Cited by 34
The prevalence of upper lip hair in black and white girls during puberty: A new standard
Lucky, A. W., Biro, F. M., Daniels, S. R., Cedars, M. I., Khoury, P. R., & Morrison, J. A. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.109790 · Cited by 33
Leuven, J. A. G., Dersjant-Roorda, M. C., Helmerhorst, F. M., de Boer, R., Neymeyer-Leloux, A., & Havekes, L. M. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90582-r · Cited by 32
Carcinoma of the endometrium in young women
Hellman, L. (1950) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(50)90387-5 · Cited by 32
Lundblad, D., & Eliasson, M. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-9 · Cited by 30
Obstetric outcome in women with polycystic ovarian syndrome
Kashyap, S., & Claman, P. (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1537 · Cited by 30
Does polycystic ovary syndrome start in childhood?
Diamanti‐Kandarakis, E., Christakou, C. D., Palioura, E., Kandaraki, E., & Livadas, S. (2008) · PubMed · Cited by 29
Simon, D., Senan, C., Gamier, P. E., Saint-Paul, M., Garat, E., Thibult, N., & Papoz, L. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90587-w · Cited by 29
Treatment of the adolescent patient with polycystic ovary syndrome
Pfeifer, S. M., & Dayal, M. B. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(03)00028-7 · Cited by 27
Andersen, A. N., Balen, A. H., Platteau, P., Devroey, P., Helmgaard, L., Arce, J.-C., & for the Bravelle Ovulation Induction (BOI) Study Group (2008) · Human Reproduction · doi:10.1093/humrep/den089 · Cited by 27
Polycystic Ovary Syndrome Is a Family Affair
Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0477 · Cited by 26
Åkerlund, M., Almström, E., Högstedt, S., & Nabrink, M. (1994) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349409013416 · Cited by 25
Continuous Glucose Monitoring During Pregnancy in Women With Polycystic Ovary Syndrome
Dmitrovic, R., Katcher, H. I., Kunselman, A. R., & Legro, R. S. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31822c887f · Cited by 23
Self-citationEarly onset adiposity: a pathway to polycystic ovary syndrome in adolescents?
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Alexandraki, K. (2007) · PubMed · Cited by 23
van der Mooren, M. J., Klipping, C., van Aken, B., Helmerhorst, F. M., Spielmann, D., & Kluft, C. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909085267 · Cited by 22
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Vassilatou, E., Lafoyianni, S., Tsarouhas, K., Papavasileiou, S., & Tzavara, I. (2008) · 10th European Congress of Endocrinology · Cited by 20
Brohall, G., Schmidt, C. B., Behre, C. J., Hulthe, J., Wikstrand, J., & Fagerberg, B. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.02.002 · Cited by 19
Godsland, I., Crook, D., Worthington, M., Proudler, A. J., Felton, C. V., Sidhu, M. S., & Stevenson, J. C. (1993) · Contraception · doi:10.1016/0010-7824(93)80142-i · Cited by 19
Hormone replacement therapy and sleep-disordered breathing
(2003) · Clinical cornerstone · doi:10.1016/s1098-3597(03)90036-6 · Cited by 16
Predictors of Endothelial Dysfunction in Young Women With Polycystic Ovary Syndrome
Kravariti, M., Naka, K. Κ., Kalantaridou, S., Kazakos, N., Katsouras, C. S., Makrigiannakis, A., Paraskevaidis, E. A., Chrousos, G. P., Tsatsoulis, A. A., & Michalis, L. K. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000206323.83912.31 · Cited by 15
Women With Polycystic Ovary Syndrome Gain Regular Menstrual Cycles When Ageing
Elting, M. W., Korsen, T. J. M., Rekers-Mombarg, L. T. M., & Schoemaker, J. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200007000-00018 · Cited by 14
Syndromes of Severe Insulin Resistance and/or Lipodystrophy
Semple, R. K., Savage, D. B., Halsall, D. J., & O’Rahilly, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00004-3 · Cited by 14
Ladson, G. M., Dodson, W., Sweet, S., Archibong, A., Kunselman, A., Demers, L., Williams, N., Coney, P., & Legro, R. (2010) · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego · doi:10.1210/endo-meetings.2010.part3.p8.p3-381 · Cited by 14
Self-citationAssessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., & Costello, M. (2011) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb04131.x · Cited by 14
Mojiminiyi, O. A., Safar, F. H., Al‐Rumaih, H., & Diejomaoh, M. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.526242 · Cited by 10
Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?
Stener‐Victorin, E., Holm, G., Labrie, F., Nilsson, L., Janson, P. O., & Ohlsson, C. (2010) · Endocrinology · doi:10.1210/endo.151.1.9996 · Cited by 10
McCartney, C. R., Prendergast, K. A., Chhabra, S., Eagleson, C. A., Yoo, R. Y., Chang, R. J., Foster, C. M., & Marshall, J. C. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000243895.96552.c9 · Cited by 9
Garg, S. K., Chase, H. P., Marshall, G., Hoops, S., Holmes, D. L., & Jackson, W. E. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199411000-00006 · Cited by 9
Costello, M., Shrestha, B., Eden, J., Sjöblom, P., & JOHNSON, N. P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005552 · Cited by 9
Meikle, A. W. (2012) · Yearbook of Medicine · doi:10.1016/s0084-3873(12)00334-3 · Cited by 8
Polycystic ovary syndrome: what is it and how should we treat it?
Cedars, M. I. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.10.032 · Cited by 7
Effects of continuous versus cyclical oral contraception: a randomized controlled trial
Mansour, D. (2008) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118908784734729 · Cited by 7
Predictors of Pregnancy in Women With Polycystic Ovary Syndrome
Rausch, M., Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., McGovern, P. G., Cataldo, N. A., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000367515.48912.b1 · Cited by 5
Self-citationKauffman, R. J., Baker, T. E., Baker, V. V., Kauffman, M. M., & Castracane, V. D. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903184084 · Cited by 4
Balen, A. H. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00314-7 · Cited by 3
Dungan, J. S. (2010) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(10)79372-3 · Cited by 3
Continuous Glucose Monitoring During Pregnancy in Women With Polycystic Ovary Syndrome
Dmitrović, R., Kunselman, A. R., & Legro, R. S. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318244ac17 · Cited by 3
Self-citationProlactin and adrenal androgen secretion
Ando, S., & Vermeulen, A. (1977) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(77)90181-9 · Cited by 2
Research works printed but not linked: 1
- [286]Tanner JM Growth and endocrinology of the adolescent. In: Gardner LI, ed. Endocrine and Genetic Diseases of Childhood and Adolescents. 2nd ed Philadelphia, PA: WB Saunders: 1975: 14.
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Self-citationPolycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Metadata
- Authors
- Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-12
- Volume
- 98
- Issue
- 12
- Pages
- 4565-4592
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5399492
- OpenAlex
- W2120973019
- Cited by
- 1,919
- References
- 356
- Citations by year
- 2026: 104 · 2025: 135 · 2024: 149 · 2023: 181 · 2022: 207 · 2021: 197 · 2020: 149 · 2019: 160 · 2018: 145 · 2017: 129 · 2016: 131 · 2015: 124 · 2014: 95 · 2013: 6
- FWCI
- 143.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- European Society of Endocrinology
- National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020595, P30DK020595)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065029)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, PCOS diagnosis, Rotterdam criteria, hyperandrogenism, ovulatory dysfunction, PCOS treatment, hormonal contraception, clomiphene citrate, metformin, insulin resistance, menstrual irregularity, hirsutism, acne, infertility, adolescents, menopausal women, weight loss, lifestyle intervention, thiazolidinediones, statins, cardiovascular risk
- MeSH terms
- Adolescent, Adult, Age Factors, Female, Humans, Middle Aged, Polycystic Ovary Syndrome, Societies, Scientific, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.